Delisting Determination, The Nasdaq Stock Market, LLC, July 19, 2024,
eFFECTOR Therapeutics, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of eFFECTOR Therapeutics, Inc., effective
at the opening of the trading session on July 29, 2024.
Based on review of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rules 5101, 5605(b)(1), 5605(c)(2),
5605(d)(2), Listing Rule 5605(e)(1)., and 5550(b)(2).
The Company was notified of the Staff determination on June 24, 2024.
The Company did not appeal the Staff determination to the Hearings
Panel. The Company securities were suspended on July 3, 2024.
The Staff determination to delist the Company securities became
final on July 3, 2024.